Financial Engines Advisors
ANAB icon

Financial Engines Advisors’s AnaptysBio ANAB Stock Holding History

Financial Engines Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-19
Closed -$2K – 111
2018
Q3 		$2K Sell
19
-1
-5% -$83 ﹤0.01% 141
2018
Q2 		$1K Buy
+20
New +$1.68K ﹤0.01% 133

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Financial Engines Advisors's ANAB Position: Q4 2018 in Review

Financial Engines Advisors sold out of AnaptysBio (ANAB) in Q4 2018, closing a stake of 19 shares — an estimated $2K sold.

Financial Engines Advisors first reported a position in ANAB in Q2 2018 and held it in 2 quarters. The position peaked at $2K in Q3 2018. 121 funds tracked by Wall St. Rank hold ANAB as of Q4 2018.

  • Financial Engines Advisors reported no remaining AnaptysBio position as of Q4 2018 after selling out during the quarter.
  • Financial Engines Advisors sold 19 AnaptysBio shares in Q4 2018, an estimated $2K.
  • Financial Engines Advisors first reported a position in AnaptysBio in Q2 2018 and held it in 2 quarters.
  • Financial Engines Advisors's AnaptysBio position peaked at $2K in Q3 2018.
  • 121 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2018.

Based on Financial Engines Advisors's 13F filing for Q4 2018, filed 8 Feb 2019.